PegBio Co., Ltd.

SHSC:2565 Stock Report

Market Cap: HK$2.7b

PegBio Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Michael Xu

Chief executive officer

CN¥102.1m

Total compensation

CEO salary percentage4.40%
CEO tenure18.2yrs
CEO ownership14.9%
Management average tenureno data
Board average tenure5.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Michael Xu's remuneration changed compared to PegBio's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025CN¥102mCN¥4m

-CN¥208m

Sep 30 2025n/an/a

-CN¥215m

Jun 30 2025n/an/a

-CN¥221m

Mar 31 2025n/an/a

-CN¥252m

Dec 31 2024CN¥110mCN¥2m

-CN¥283m

Dec 31 2023CN¥27mCN¥2m

-CN¥279m

Compensation vs Market: Michael's total compensation ($USD15.07M) is above average for companies of similar size in the Hong Kong market ($USD412.96K).

Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.

CEO

Michael Xu (61 yo)

18.2yrs
Tenure
CN¥102,067,000
Compensation

Dr. Min Xu, also known as Michael has been an Independent Non-Executive Director of Kintor Pharmaceutical Ltd since 12 August 2019. He is responsible for providing independent advice and judgement. Dr. Xu...

Board Members

NamePositionTenureCompensationOwnership
Min Xu
Executive Chairman of the Board & GM18.2yrsCN¥102.07m14.85%
HK$ 400.8m
Xiaojun Wang
CFO & Executive Director5.6yrsCN¥3.84mno data
Yuhong Xu
Non-Executive Director5.8yrsno data1.74%
HK$ 47.0m
Ting Zhai
Non-Executive Director5.3yrsno datano data
Yongjun Kong
Supervisor5.6yrsno datano data
Xiangjun Zhou
Non-Executive Director5.8yrsno data1.6%
HK$ 43.3m
Hongkai LI
Non-Executive Director5.8yrsno datano data
Yangyang Chen
Independent Non-Executive Director5.6yrsCN¥100.00kno data
Jiancun Zhang
Independent Non-Executive Director5.6yrsCN¥100.00kno data
Mengjiao Wang
Chairman of the Supervisory Committee3.7yrsno datano data
Dong Li
Supervisor2.4yrsno datano data
Yik Lam Liao
Independent Non-Executive Directorless than a yearno datano data
5.6yrs
Average Tenure
53yo
Average Age

Experienced Board: 2565's board of directors are considered experienced (5.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/23 20:16
End of Day Share Price 2026/07/23 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PegBio Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.